Seminars in Oncology
Volume 35, Supplement 2 , Pages S15-S21, April 2008

Preclinical Investigations With Epothilones in Breast Cancer Models

  • Howard A. Burris III

      Affiliations

    • Corresponding Author InformationAddress correspondence to Howard A. Burris III, MD, FACP, Sarah Cannon Research Institute, 250 25th Avenue North, Suite 110, Nashville, TN 37203

Sarah Cannon Research Institute, Nashville, TN.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Burris has received honoraria from Bristol-Myers Squibb Company, Kosan Biosciences, and Novartis Pharmaceuticals Corporation.

PII: S0093-7754(08)00041-9

doi:10.1053/j.seminoncol.2008.02.002

Seminars in Oncology
Volume 35, Supplement 2 , Pages S15-S21, April 2008

Article Tools

* Image Usage & Resolution